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Abstract:  An atisane diterpene was isolated from Xylopia langsdorfi ana St. Hilaire & 
Tulasne, Annonaceae, leaves, ent-atisane-7α,16α-diol (xylodiol). Preliminary study 
showed that xylodiol was cytotoxic and induced differentiation on human leukemia 
cell lines. However, the molecular mechanisms of xylodiol-mediated cytotoxicity 
have not been fully defined. Thus, we investigated the anti-tumor effect of xylodiol 
in human leukemia HL60 cell line. Xylodiol induced apoptosis and necrosis. 
HL60 cells treated with xylodiol showed biochemical changes characteristic of 
apoptosis, including caspases-8, -9 and -3 activation and loss of mitochondrial 
transmembrane potential (∆ψm). However, there was a condensation rather than 
swelling of mitochondria. Moreover, the formation of condensed mitochondria 
and the loss of ∆ψm occurred downstream of caspase activation. Cyclosporine A 
did not protect HL60 cells from the cytotoxic effects of xylodiol, suggesting that 
the loss of ∆ψm is a late event in xylodiol-induced apoptosis. Oxidative stress was 
involved in xylodiol-induced apoptosis. Thus, we conclude that activated caspases 
cleave cellular proteins resulting in mitochondrial damage leading to mitochondrial 
condensation, loss of ∆ψm and ROS release from the mitochondria. ROS can further 
induce and maintain a collapse of ∆ψm leading to cellular damage through oxidation 









 Xylodiol (1), an atisane diterpene, was isolated 
from Xylopia langsdorfiana St.Hilaire & Tulasne, 
Annonaceae, leaves and characterized as ent-atisan-
7α,16α-diol (Tavares et al., 2007). Atisane diterpenes 
are rare in the Annonaceae family, having been recorded 
only in Xylopia aromatica (Morais & Roque, 1988). 
This group of compounds is little studied biologically 
thus far. However, other atisane-type diterpenes showed 
anti-HIV (Sun et al., 2003) and insecticidal activities, 
and are cytotoxic to mouse leukemia cells P388 (Perry 
et al., 2001). We have previously reported that xylodiol 
inhibits cell growth and induces differentiation in 
human leukemia cell lines (HL60, U937 and K562) 
(Castello-Branco et al., 2009). Moreover, xylodiol 
showed weak cytotoxicity against V79 cells and rat 
hepatocytes (Tavares et al., 2007).
 The ability to induce cell apoptosis is an 
important property of candidate anti-cancer drugs. Two 
major pathways, the Fas/TNF death receptor pathway 
and the mitochondria-dependent pathway, lead to the 





 Death receptor stimulation activates an extrinsic 
apoptotic program which results in caspase-8 activation 
(Thorburn, 2004). Caspase-8 directly activates effectors 
caspases including caspase-3, one of the major caspases 
participating in the execution phase of apoptosis. 
Activated caspase-3 cleaves many substrates, including 
poly (ADP-ribose) polymerase (PARP), a DNA repair 
enzyme, which leads to inevitable cell death. In 
addition, caspase-8 can activate Bid, which then triggers 
the mitochondrial pathway (Liu et al., 2006). In this 
case, the mitochondrial (intrinsic) pathway is thought 
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to be an amplifier signal of the extrinsic pathway. 
It has been proved that in mitochondrial-mediated 
apoptosis, a central role is played by mitochondrial 
permeability transition (MPT), a process that leads 
to an increase in inner membrane permeability (Ly 
et al., 2003). This phenomenon is regulated by the 
opening of a large conductance channel known as the 
permeability transition pore (MPTP). Opening of this 
non-selective pore provokes the dissipation of inner 
transmembrane potential (∆ψm), matrix swelling and 
outer membrane disruption, thus leading to the release 
of apoptogenic factors including cytochrome c. The 
released cytochrome c, together with Apaf-1, activates 
caspase-9, which in turn proteolytically activates 
downstream caspase-3 (Jiang & Wang, 2004).
 Apoptosis implicates also reactive oxygen 
species (ROS)-dependent mechanisms. A role for 
oxidative stress in the induction of apoptosis is 
suggested by the observations that low levels of 
ROS induce apoptosis whereas antioxidants such as 
N-acetylcysteine (NAC) inhibit cell death. Additionally, 
ROS generation occurs following the treatment of cells 
with various agents, including chemotherapeutic drugs 
(Chandra et al., 2003).
 In the present study, we investigated the anti-
proliferative and apoptosis-inducing effects of xylodiol 




 Xylodiol (1) was obtained from Xylopia 
langsdorfiana St.Hilaire & Tulasne, Annonaceae, 
leaves as previously described (Tavares et al., 2007).
Cell culture
 The HL60 cells, derived from a patient with 
acute promyelocytic leukemia, were of the laboratory 
of cellular metabolism and regulation kindly provided 
by Dr Rui Curi, Department of Physiology and 
Biophysic, Institute of Biomedical Sciences, USP, São 
Paulo, Brazil. HL60 cells were maintained in RPMI 
1640 (Sigma®) supplemented with 10% FBS (Sigma®), 
100 IU/mL penicillin and 100 µg/mL streptomycin 
(Sigma®) at 37 °C in a humidified atmosphere of 5% 
CO2 and 95% air.
Annexin V-FITC
 Apoptotic cells were detected using 
ApoDETECTTM Annexin V-FITC kit obtained from 
Zymed Laboratories® Inc., USA. HL60 cells (3 × 105 
cells/mL) were treated with 0 (control), 50, 100 and 
150 μM xylodiol for 12, 24, 48 and 72 h. After washing 
in PBS, pH 7.4, the cells (1 × 106 cells/mL) were 
resuspended in binding buffer and annexin V-FITC was 
added. The cells were incubated at room temperature for 
10 min and washed with binding buffer (10 mM Hepes/
NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2). After 
the addition of 20 µg/mL propidium iodide (Sigma), 
the cells were analyzed by flow cytometry using a 
FACS Calibur flow cytometer (Becton Dickinson, San 
Jose, CA, USA). Data were acquired with CellQuest 
acquisition software, version 3.3 (BD Biosciences). A 
total of 10000 events were collected for each sample 
and analyzed with WinMDI, version 2.8.
Assay for mitochondrial swelling
 For the detection of mitochondrial swelling, 
the mitochondria were isolated from HL60 cells after 
treatment with 0, 50, 100 and 150 μM xylodiol for 3, 
6, 12 and 24 h, according to Schneider & Hogeboom 
(1950) with some modifications. The cells were 
centrifuged at 12 100 × g for 10 min at 0 to 4 ºC. The 
pellet was suspended in 250 mM sucrose containing 
0.3 mM EGTA buffered with 1.0 mM Hepes, and again 
centrifuged under the same conditions. The pellet was 
suspended in 250 mM sucrose, obtaining a mitochondrial 
suspension approaching a concentration of 100 µg/
mL protein, determined by the Bradford method. 
Mitochondrial swelling was determined according to 
Anazetti et al. (2003) with some modifications. The 
mitochondria were suspended in CFS buffer (220 
mM mannitol/68 mM sucrose/2.0 mM NaCl/5.0 mM 
KH2PO4/2.0 mM MgCl2/10 mM Hepes-NaOH, pH 
7.4/5.0 mM succinate/2.0 µM rotenone). Absorbance 
was measured at 520 nm at indicated times for 15 min at 
25 ºC using a spectrophotometer (Beckman DU640B). 
A decreased absorbance is consistent with an increase 
in mitochondrial swelling.
Assay for mitochondrial permeability transition
 The mitochondrial membrane potential (MMP) 
was evaluated in HL60 cells after treatment with 0, 
50, 100 and 150 μM xylodiol for 12, 24, 48 and 72 h. 
Cells (1 x 106 cells) were centrifuged and resuspended 
in phosphate buffer. JC-1 (BD Biosciences®) was 
added at a final concentration of 5 ng/mL. After 
washing with cold PBS, the samples were analyzed 
by flow cytometer. JC-1 emits light at red and green 
wavelengths according to the concentrations absorbed 
by the mitochondria: at a normal membrane potential, 
JC-1 forms aggregates which emit a green-orange 
fluorescence, but decreases in the MMP values result 
with an increase in JC-1 monomer, which then emits 
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only green fluorescence. Thus, the decreased JC-1 
fluorescence ratio of red aggregates/green monomers 
linked to the loss of ∆ψm was detected. The cells were 
analyzed by flow cytometry using a FACS Calibur flow 
cytometer (Becton Dickinson, San Jose, CA, USA).
Activation of caspase-3, -8 and -9 assay
 Caspase activities were measured using Caspase 
Detection Kits by flow cytometry (Calbiochem®). The 
assays were based on the measurement of fluorescence 
intensity by flow cytometry of the inhibitor conjugated to 
FITC, the fluorescent markers FITC-DEVD-FMK, FITC-
IETD-FMK, FITC-LEHD-FMK, which bind to activated 
caspase-3, -8 and -9, respectively. HL60 cells at 1 × 106/
mL were incubated with xylodiol (0, 50, 100 and 150 μM) 
for 3, 6, 12 and 24 h at 37 ºC in a 5% CO2 incubator. The 
cells were separated into 300-μL volumes for each of the 
induced and control cultures in 1,5 mL tubes, and then, 
1 μL of inhibitor conjugated to FITC, for each caspase, 
was added to each tube and the contents incubated for 1 h. 
The cells were centrifuged and the pellet was resuspended 
in 0.5 mL of wash buffer and again centrifuged under the 
same conditions. The pellet was resuspended in 300 μL of 
wash buffer and placed on ice. The cells were analyzed 
by flow cytometry using a FACS Calibur flow cytometer 
(Becton Dickinson, San Jose, CA, USA).
Measurement of lipid peroxidation by the TBARS 
assay
 The extent of xylodiol-induced lipid 
peroxidation was determined by the reaction of 
thiobarbituric acid (TBA) with malondialdehyde 
(MDA), a product formed by lipid peroxidation (Wallin 
et al., 1993). The cells were previously treated with 
xylodiol at different concentrations (0, 50, 100 and 150 
µM). The assays were carried out according to Salgo & 
Pryor (1996), with slight modifications. HL60 cells (5 
× 106) were lysed with 15 mM Tris/HCl (5 mL) for 60 
min. The lysate was mixed with 2 mL of precipitating 
solution (TCA 0.4 g/mL) followed by incubation with 
TBA (6.7 mg/mL) for 15 min at 100 ºC, after which 
the mixture was centrifuged (750 × g for 10 min). The 
relative fluorescence was measured with excitation 
at 515 nm and emission at 553 nm in a Sim-Aminco 
(SPF 500) spectrophotofluorimeter. The results 
were expressed as percentages of TBARS formed as 
compared to the control.
Cell viability
 To assess cell viability and the protective effect 
of cyclosporine A (CSA), reduced glutathione (GSH) 
and N-acetylcysteine (NAC), all of them obtained from 
Sigma, HL60 cells were seeded (3 × 105 cells/mL) in 
96-well plates containing 1 μM CSA, 1 mM GSH or 1 
mM NAC, and incubated with different concentrations 
of xylodiol (0, 50, 100 and 150 μM) for 72 h. Cell 
viability was determined by MTT (Sigma®) reduction. 
The tetrazolium reduction assay was performed as 
described by Denizot & Lang (1986). Briefly, 0.1 
mL of serum-free medium containing MTT (1 mg/
mL) was added to each well. After 4 h of incubation, 
the supernatant was removed and the blue formazan 
product obtained was dissolved in 0.1 mL ethanol with 
mixing for 15 min on a microplate shaker, after which 
the absorbance at 570 nm was read.
Statistical analysis
 Data for each assay were expressed as 
means±SD of three independent experiments run in four 
replicates. The results were expressed as percentages of 
controls and the computer software package “Origin” 
was used to determine the IC50 values (concentration 
that produced 50% inhibition of the parameter 
evaluated). Statistical comparisons were done using 
one-way ANOVA or Student’s t-test as calculated by 
Origin, version 6.0 p<0.05 was considered statistically 
significant.
Results
Xylodiol decreases the viability of human leukemia 
cells HL60
 As shown in Figure 1, xylodiol inhibited the 
growth of HL60 cells in a concentration-dependent 
manner in the absence of CSA. CSA is one of the most 
employed mitochondrial permeability transition (MPT) 
inhibitors. However, the addition of CSA did not protect 
HL60 cells from the cytotoxic effects of xylodiol.
Figure 1. Viability of cultured HL60 cells after treatment 
with 50, 100 and 150 μM xylodiol for 72 h in the presence and 
absence of CSA. The endpoint evaluated was MTT reduction. 
All results were expressed as mean±SD of three experiments 
with four replicates. *p<0.01, compared with control.
Xylodiol from Xylopia langsdorfi ana induces apoptosis in HL60 cells
Marianna Vieira S. Castello-Branco et al.
Rev. Bras. Farmacogn. Braz. J. Pharmacogn. 21(6): Nov./Dec. 20111038
Xylodiol induces apoptosis and necrosis in HL60 cells
 To further characterize xylodiol-induced 
apoptosis, we performed a biparametric cytofluorimetric 
analysis using PI and annexin V-FITC, which stain 
DNA and phosphatidylserine residues, respectively. 
Flow cytometric analysis showed that xylodiol induced 
apoptosis and necrosis in a concentration and time-
dependent manner in HL60 cells treated with 50, 100 
and 150 μM xylodiol for 12, 24, 48 and 72 h (Figure 
2 and 3). HL60 cells treated with these concentrations 
for 6 h did not show any alteration in the annexin V/
PI staining (data not shown). Flow cytometric analysis 
revealed that at 72 h, the percentage of annexin V- 
and PI-positive cells (late stages of apoptosis and/or 
necrotic cells) was high as 81%.
Figure 2. Flow cytometric analysis of HL60 cells treated 
with xylodiol. Flow cytometry dot plots for the simultaneous 
binding of annexin V-FITC and propidium iodide (PI) uptake 
by following exposure of HL60 cells to 0, 50, 100 and 150 
µM of xylodiol for 12, 24, 48 and 72 h. The numbers at the 
bottom right quadrant of each dot plot represent the percentage 
of cells in early apoptosis (annexin V-positive, PI-negative). 
Numbers at the top right quadrant represent the percentage 
of cells in late apoptosis and/or secondary necrosis (annexin 
V-positive, PI-positive). The data are representative of three 
separate experiments.
Xylodiol-induced apoptosis is dependent on caspase 
activation
 There was a significant increase in caspase-8 
activity in HL60 cells treated with 50, 100 and 150 
μM xylodiol as compared to the control (Figure 4A). 
Caspase-8 was the first to be activated after 3 h exposure 
to 50 and 150 μM xylodiol. The peak level of active 
caspase-8-positive cells at 12 h was about 65% at 150 
μM xylodiol. A decrease in caspase-8 activity occurred 
after 24 h of treatment. Caspase-9 was activated only 
after 12 h of treatment with 150 μM xylodiol (Figure 4 
B). Significant activation of caspase-3 by xylodiol was 
detected especially after 6, 12 and 24 h of treatment 
(Figure 4 C). These results indicate an involvement of 
caspase-8 rather than caspase-9 in apoptosis induced by 
xylodiol. In addition, these findings strongly suggest 
that xylodiol induces apoptosis at least partially via the 
caspase-3 pathway.
Figure 3. Induction of cell death in response to 50, 100 
and 150 μM xylodiol. After 12, 24, 48 and 72 h, cells were 
submitted to annexin V/PI double staining and analyzed by 
FACS to determine the percent cell death, which included both 
early and late apoptotic cells. The data presented represent 
the means of the percent cell death±SD from three separate 
experiments. *p<0.05 and **p<0.01, compared with control.
Xylodiol-induced mitochondrial alterations
 An increase in mitochondrial swelling of about 
15% was seen after treatment of HL60 cells with 50 
μM xylodiol for 12 and 24 h (Table 1). In contrast, 
a decrease in mitochondrial swelling (2.5-26.7%) 
occurred in cells treated with 100 and 150 μM xylodiol 
(Table 1). Changes in mitochondrial membrane potential 
(MMP) were monitored after staining with JC-1. Figure 
5 shows a clear increase in the percentage of cells 
that emitted only green fluorescence after xylodiol 
treatment (bottom right quadrant) in a concentration- 
and time dependent manner in HL60 cells treated with 
50, 100 and 150 μM xylodiol for 12, 24, 48 and 72 h. 
HL60 cells treated with these concentrations for 6 h 
did not show any alteration in MMP (data not shown). 
As shown in Figure 6, there was significant decrease in 
the ratio of red fluorescence to green fluorescence after 
exposure to 50, 100 and 150 μM xylodiol, showing a 
loss of ∆ψm.
Xylodiol-induced apoptosis is associated with oxidative 
stress
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generation of lipid peroxidation products, cell viability 
was determined in the presence of the antioxidants 
GSH and NAC. As revealed in Figure 8, GSH and NAC 
partially reduced the cytotoxity of xylodiol.
Table 1. Percent increase and decrease (-) in mitochondrial 
swelling in treated cells compared to control cells. The data 
are representative of three separate experiments.
Treatment (µM)
Mitochondrial swelling (%)
Time of treatment (h)
3 6 12 24
Xylodiol 50 - 2.5 - 17.1 15.2 13.8
Xylodiol 100 - 10.5 - 8.3 - 20.2 - 26.7
Xylodiol 150 - 25.7 - 19.0 - 6.4 - 18.9
Figure 6. Induction of loss of mitochondrial membrane 
potential (∆ψm) by xylodiol. HL60 cells treated with 50, 
100 and 150 μM xylodiol for 12, 24, 48 and 72 h were 
analyzed. Alteration in mitochondrial membrane potential 
was measured by flow cytometry using JC-1 staining. Data 
presented as means±SD of three independent experiments. 
*p<0.05 and **p<0.01, compared with control.
 To investigate any relevance of oxidative stress 
in xylodiol-induced apoptosis, we examined the degree 
of lipid peroxidation after treatment with xylodiol for 
12, 24 and 48 h. As shown in Figure 7, treatment with 
50, 100 and 150 μM xylodiol for 24 and 48 h led to a 
marked increase in the percentage of TBARS formed. 
TBARS production increased by about 70% and 80% 
after exposure to 100 μM xylodiol for 24 and 48 h, 
respectively.
Figure 5. Xylodiol-mediated depolarization of mitochondrial 
membrane. After 12, 24, 48 and 72 h of treatment with 50, 
100 and 150 μM xylodiol, the cells were stained with the 
mitochondria selective dye JC-1 and analyzed by FACS. 
Cells with normal polarized mitochondrial membrane emit 
green-orange fluorescence (top right quadrant). The number 
in the bottom right quadrant of each dot plot represents 
the percentage of cells that emit only green fluorescence 
indicating loss of ∆ψm. The data are representative of three 
separate experiments.
Antioxidants protect against xylodiol-induced 
apoptosis
 To examine whether the cytotoxic effect 
induced by xylodiol in HL60 cells was due to the 
Figure 4. Xylodiol-induced increase in active caspase-8-positive (A), caspase-9-positive (B) and caspase-3-positive (C) HL60 cells. 
Data are presented as means±SD from three separate experiments. *p<0.05 and **p<0.01, compared with control.
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Figure 7. Determination of lipid peroxidation in HL60 cells 
after exposure to 50, 100 and 150 μM xylodiol for 12, 24 
and 48 h. The data are means±SD from three independent 
experiments. *p<0.05 and **p<0.01 compared with control.
Figure 8. Protective effect of GSH and NAC on the viability 
of HL60 cells treated with 50, 100 and 150 μM xylodiol for 
72 h was evaluated by MTT reduction. Each column displays 
the mean±SD of three experiments in four replicates. *p<0.05 
compared to the groups treated only with xylodiol.
Discussion
 Natural products or their structural relatives 
comprise about 50% of the drugs used in cancer 
chemotherapy (Ito et al., 2004). Anticancer drugs 
act by interfering with cell proliferation or, in most 
cases, by inducing programmed cell death, known as 
apoptosis (Cheson, 2002). Our studies revealed for the 
first time the anticancer action mechanism of an atisane 
diterpene. 
 In apoptotic cells, the membrane phospholipid 
phosphatidylserine (PS) is translocated from the inner 
to the outer leaflet of the plasma membrane, thereby 
exposing PS to the external cellular environment. 
Annexin V is a phospholipid-binding protein with 
high affinity for PS. The findings of annexin-V/PI 
staining indicate that the xylodiol induces apoptosis 
and necrosis. 
 The morphological and biochemical changes 
of apoptosis are orchestrated by a set of cysteine 
proteinases that are activated during apoptosis, the 
caspases (Lavrik et al., 2005). In this study, our findings 
strongly suggest that xylodiol induced apoptosis is at 
least partially via the caspase-3 pathway. Caspase-8 
and caspase-9 are initiator caspases in apoptotic 
pathways triggered by engagement of death receptors 
and by cytochrome c release from the mitochondria 
to the cytosol, respectively (Lavrik et al., 2005). Our 
data indicate an involvement of caspase-8 rather than 
caspase-9 in apoptosis induced by xylodiol. The role of 
membrane death receptor-mediated apoptosis is known 
to be one of the pathways to caspase-8 activation. 
However, it has been reported that anticancer drugs 
induce apoptosis and caspase-8 cleavage in a Fas-
associated death domain (FADD)-independent 
manner, suggesting that death receptor activation is 
not prerequisite for drug-induced caspase-8 activation 
(Wesselborg et al., 1999). 
 The role of the mitochondria in the mechanism 
of cell death has been studied extensively. In this study, 
we observed mitochondrial condensation in HL60 
cells treated with xylodiol, indicated by a decrease in 
mitochondrial swelling. Recently, some investigators 
have reported similar findings of condensed mitochondria 
in connection with apoptosis (Jia et al., 1997; Zhuang 
et al., 1998; Ikebukuro et al., 2000). In some systems, 
there appears to be a progression from the condensed 
to the ultracondensed form followed by deletion of the 
organelle (Jia et al., 1997; Zhuang et al., 1998). It has 
been shown that before cells exhibit common signs of 
nuclear apoptosis, they undergo a reduction in ∆ψm 
which is a consequence of the opening of MPTP. It has 
also been suggested that large amplitude mitochondrial 
swelling, possibly caused by MPTP opening, is 
required for the release of apoptogenic factors from 
mitochondria (Jia et al., 1997; Ly et al., 2003). Other 
reports suggested that mitochondrial condensation is 
associated with the apoptotic signaling process and is 
not a consequence of apoptotic shrinkage (Jia et al., 
1997). Zhuang et al. (1998) described the condensation 
of mitochondria and the reduction in ∆ψm as being 
downstream of the release of apoptogenic factors, 
such as cytochrome c. In addition, it was proposed 
that the formation of condensed mitochondria occurs 
downstream of caspase activation (Zhuang et al., 1998). 
Our data support the hypothesis that activated caspases 
cleave cellular proteins resulting in mitochondrial 
damage leading to mitochondrial condensation and loss 
of ∆ψm. MPT inhibitors have become useful tools in 
the study of the processes of cell death in relation to 
mitochondrial physiology. One of the most employed 
inhibitors is cyclosporine A (CSA) (Marques-Santos et 
al., 2006). The observation that CSA did not protect 
HL60 cells against the cytotoxic effects of xylodiol 
supports the hypothesis that the loss of ∆ψm is a late 
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event in xylodiol-induced apoptosis.
 The role of the cellular redox state during 
apoptosis was examined by determining the extent of 
lipid peroxidation. The increase in TBARS production 
occurred at only 24 and 48 h after treatment with xylodiol. 
Mitochondria are a source of ROS during apoptosis 
and reduced mitochondrial membrane potential leads 
to increased generation of ROS and apoptosis (Huang 
et al., 2006). ROS can further induce and maintain the 
collapse of ∆ψm, leading to cellular damage through the 
oxidation of lipids and proteins, resulting in apoptotic 
cell death (Huang et al., 2006). Therefore, we speculate 
that the generation of ROS could be an important factor 
in xylodiol-induced apoptosis. In fact, the disruption 
of mitochondrial membrane potential by xylodiol was 
accompanied by an increase in TBARS production. 
In addition, antioxidants such as GSH and NAC were 
examined in the present study as to whether ROS 
production is an essential event for xylodiol-induced 
apoptosis. The ability of the antioxidants to lower the 
cytotoxic effects of the xylodiol in HL60 cells provides 
evidence that ROS are intermediates of xylodiol-
induced apoptosis. 
 Altogether, our results reported herein 
show that xylodiol induces apoptosis and necrosis 
in HL60 leukemia cells. Our preliminary research of 
the mechanisms indicates that xylodiol cytotoxicity 
involves lipid peroxidation and that apoptosis 
induced by xylodiol is associated with mitochondrial 
condensation and loss of ∆ψm which occur downstream 
of caspase activation.
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